drugset / Trial / NCT01940731
Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
NaSingle-groupOpen-labelTreatment
Summary
1. To evaluate the clinical and microbiological efficacy and safety of Colistimethate sodium Injection Vial to treat adults with hospital-acquired pneumonia . 2. To Learn the pharmacokinetic characteristics of continuous intravenous infusion of Colistimethate sodium.
Timeline
- Start
- 2013-10
- Primary completion
- 2014-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colistimethate | Unknown | 2.5 mg/kg | Intravenous |
| Subject | Colistimethate | Unknown | 3 mg/kg | Intravenous |
| Subject | Colistimethate | Unknown | 3.8 mg/kg | Intravenous |
| Subject | Colistimethate | Unknown | 5 mg/kg | Intravenous |
| Subject | Colistimethate | Unknown | 230 mg | Intravenous |
| Subject | Colistimethate | Unknown | 300 mg | Intravenous |